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Bird Fancier’s Lung Diagnosis in Times of
COVID-19
Diagnóstico de la neumonitis de los avicultores en tiempos de la
COVID-19
Dear Editor,
The identification of bilateral ground-glass opacifications on
thoracic computed tomography (CT) in the COVID-19 ongoing pan-
demic, supports the diagnosis of SARS-CoV-2 infection. Although
COVID-19 pneumonia may  present with this typical imaging pat-
tern, it is important to highlight that even in an acute clinical setting
this pattern it is a non-specific imaging finding and other condi-
tions such as pulmonary oedema, non-infectious pneumonitis and
infectious interstitial pneumonia by other pathogens need to be
considered.1,2
We  report the case of a 69-year-old woman who presented
to our department in April 2020, during COVID-19 pandemic. On
admission, the patient described a 10 day history of progressive
dyspnoea and chest pain. There was a 11% of weight loss and occa-
sional wrist and ankle arthralgia, without myalgia, fever or cough.
Relevant clinical history included hypertension, allergic rhinosi-
nusitis and psoriasis (on cyclosporine treatment, discontinued in
2018). On physical exam she had tachypnoea, inspiratory crack-
les in the lung bases and a peripheral oxygen saturation (SpO2)
of 89%. Laboratory findings revealed normal white blood cell
count, an increased high-sensitivity C-reactive protein (3.70 mg/dL
N.R.<0.5 mg/dL), lactate dehydrogenase (308 U/L >250 U/L) and
erythrocyte sedimentation rate (60 mm/h  <20 mm/h) with procal-
citonin value within the reference range (0.09 ng/mL <0.5 ng/mL).
Immunological and microbiological studies (including a swab test
for RT-PCR SARS-CoV-2) were negative. Chest radiography showed
diffuse bilateral symmetric ill-defined air-space opacities. Chest CT
displayed diffuse bilateral ground-glass opacities with lobular spa-
red areas (mosaic attenuation pattern), ill-defined centrilobular
ground-glass nodules and mild interlobular thickening, however
without the characteristic distribution of COVID-19 (Fig. 1).
The patient was admitted with the presumptive diagnosis of
SARS-CoV-2 pneumonia, based on a high probability diagnosis’
score,3 pending a second negative nasopharyngeal swab test for
RT-PCR SARS-CoV-2.
On a more detailed clinical history, the patient acknowledged to
have a budgerigar at home for about one year. Flexible bronchos-
copy showed diffusely friable mucosa. Bronchoalveolar lavage fluid
cell count was  consistent with alveolitis (28% alveolar macropha-
ges, 42% lymphocytes, 24% neutrophils and 6% eosinophils, with a
CD4/CD8 ratio of 2). A diagnosis of Bird Fancier’s Lung was con-
firmed by strongly positive precipitins to budgerigar. The patient
initiated inhaled steroids with rapid symptomatic improvement
and was discharged home with rest SpO2 of 98%. The budgeri-
gar was  removed from the patient’s environment and she became
totally asymptomatic after a short steroid treatment.4,5
Hypersensitivity pneumonitis (HP) is an immunologically non-
IgE-mediated lung disease due to the repetitive inhalation of
antigens. Most cases are secondary to residential environmen-
tal exposure, particularly birds. Given the time length to onset
of symptoms, the causal epidemiological link is often initially
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Fig. 1. Chest CT axial (a, b) and coronal (c) images demonstrating diffuse bilateral ground-glass opacities with lobular spared areas (mosaic attenuation pattern), ill-defined
centrilobular ground-glass nodules in the upper lobes and mild interlobula.
unrecognized. The clinical symptoms and imaging findings are
nonspecific and may  mimic  COVID-19 in the ongoing pande-
mic. Nevertheless, other medical conditions may  present with a
similar clinical and radiographic findings. In the pandemic time of
COVID-19, the presence of alveolar infiltrates urges to consider the
hypothesis of this infection. Atypical clinical findings and negative
swabs compel us to exclude other etiologies, being of the utmost
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